Award
National Cancer Institute 1R43CA298492-01A1
Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy
Recipient
National Cancer Institute (NCI)
Award Amount
$399,300.00
Ceiling
$399,300.00
Awarded
September 08, 2025
Identifier
1R43CA298492-01A1
Award for developing a cancer immunotherapy platform using spleen-targeted RNA delivery, including preclinical testing in HPV and melanoma models, preparing for Phase II SBIR application.
Description
This project aims to develop a novel cancer immunotherapy platform using spleen-targeted RNA delivery technology. The project involves preclinical testing in HPV and melanoma models. The goal is to prepare for a Phase II SBIR application.